December, 05th | 14:30 - 14:33
Clinical impact of the port delivery system with ranibizumab (pds) on fibrosis in patients with neovascular age-related macular degeneration (namd) in the phase 3 archway trial
HEINRICH DOMINIC
Full program
Add to calendar